Efficacy of 0.05% Epinastine and 0.1% Olopatadine for Allergic Conjunctivitis as Seasonal and Preseasonal Treatment

Clinical Ophthalmology- New Zealand

doi 10.2147/opth.s141279

Full Text

Abstract

Available in

Categories

Date

September 1, 2017

Authors

Takanori Mizoguchi

Nobuchika Ogino

Publisher

Informa UK Limited

Related search

Comparative Study of Olopatadine 0.1% and Lodoxamide 0.1% in Treatment of Seasonal Allergic Conjunctivitis

Annals of the College of Medicine, Mosul

English

Olopatadine/Mometasone Combination Nasal Spray for the Treatment of Seasonal Allergic Rhinitis: A Pooled Analysis of Efficacy and Safety

Journal of Allergy and Clinical Immunology

English

A Prospective Study of Efficacy and Safety of Olopatadine Versus Azelastine in Allergic Conjunctivitis at a Tertiary Care Hospital

International Journal of Basic & Clinical Pharmacology

English

Epinastine Hydrochloride for Pediatric Allergic Rhinitis

Otolaryngology - Head and Neck Surgery

Otorhinolaryngology

English

Efficacy of Montelukast and Levocetirizine as Treatment for Allergic Rhinitis

Journal of Allergy & Therapy

English

Correlation of Features of Allergic Rhinitis and Allergic Conjunctivitis With Treatment Modalities

Journal of Advances in Medicine and Medical Research

English

Ocular Tolerability and Efficacy of Ebastine Colloidal Formulation in Allergic Conjunctivitis

International Journal of Pharmaceutical Sciences and Drug Research

English

Allergic Conjunctivitis

Journal of Allergy

English

Retrospective Review on the Use of Topical Cyclosporin a 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese

The Scientific World Journal

Molecular Biology

Environmental Science

English